Muscle capillary basement membrane width is a sensitive marker for the presence of diabetic microangiopathy. Studies have indicated that genetic factors and alterations in glucose metabolism influence muscle capillary basement membrane width. To define the role of these factors we have measured muscle capillary basement membrane thickness in controls, insulin dependent diabetics, and individuals with diabetes secondary to the ingestion of Vacor, a rat poison, which results in hyperglycemia. Hemoglobin A1 concentrations were increased in both diabetic groups, but hemoglobin Al levels and the duration ofdiabetes were similar in the two diabetic groups. The muscle capillary basement membrane width was increased to a similar extent in the insulindependent diabetics (control, 1,781±46 vs. IDD, 2,287±144 A, P < 0.001) and in the Vacor diabetic group (2,320±149 A, P < 0.001). In the insulin-dependent diabetic group, 63% of the patients had a muscle capillary basement membrane width greater than two standard deviations above the mean of the controls, while in the Vacor diabetic group this figure was 56%. Despite the relatively short duration of diabetes (6.2±0.3 yr), 44% of the Vacor diabetic patients had retinopathy and 28% had proteinuria. The present study provides strong evidence that even in the absence of genetic diabetes mellitus, hyperglycemia or some other abnormality related to insulin lack can cause microvascular changes.
Introduction
Muscle capillary basement membrane thickening is a sensitive marker for the presence ofdiabetic microangiopathy (1) (2) (3) (4) . The mechanism by which diabetes results in microangiopathy and muscle capillary basement membrane thickening is unknown, but a number of studies have indicated that alterations in glucose metabolism or other abnormalities that occur in association with poorly controlled diabetes lead to an increase in muscle capillary basement membrane width. Raskin et al. longitudinally quantitated muscle capillary basement membrane width in insulindependent diabetics (IDD)' who were either tightly controlled by continuous subcutaneous insulin infusion or treated conven-tionally (5) . These investigators observed that in the tightly controlled diabetics, muscle capillary basement membrane width decreased, whereas in the conventionally treated group, muscle capillary basement membrane width at two years was not significantly different from baseline (5) . In addition, muscle capillary basement membrane width, after two years oftight control, was similar in the tightly controlled diabetic group and in nondiabetic controls (5) . Camerini-Davalos et al. examined the effect of glipizide or placebo treatment on muscle capillary basement membrane width in patients with impaired glucose tolerance (6) . In the glipizide-treated group glucose tolerance improved, and muscle capillary basement membrane decreased to a width that was no different than that observed in controls (6) . In contrast, in the placebo-treated group there was no change in glucose tolerance and muscle capillary basement width increased (6) . In addition to these controlled studies, Peterson et al. reported that meticulous diabetic control for 8-10 mo decreased muscle capillary basement membrane width in six ofseven IDD (7) . Finally, Soskeno et al. serially biopsied a group of IDD and found that at least in the postpubertal individuals, the change in muscle capillary basement membrane width correlated positively with indicies of glycemic control (8) . Taken together, these studies indicate that the degree of metabolic control in diabetic individuals affects muscle capillary basement membrane thickness.
It should be recognized, however, that several lines of evidence have suggested that genetic factors may also play an important role in the development of muscle capillary basement membrane thickening in humans with diabetes mellitus. In 1968, Siperstein, Unger, and Madison published data demonstrating that thickening of the muscle capillary basement membrane occurs before the onset of clinically demonstrable abnormalities in glucose metabolism (1) . Specifically it was noted that in a group of nondiabetic offspring of two diabetic parents, muscle capillary basement membrane was significantly thickened in comparison to controls, a difference that persisted after age matching (1) . Approximately 50% of the nondiabetic offspring oftwo diabetic parents had muscle capillary basement membrane thickening greater than two standard deviations above the mean of controls (1) . Not unexpectedly, the finding of an abnormality in muscle capillary basement membrane width in nondiabetics genetically predisposed to the development of diabetes caused a great deal of controversy. Williamson (9) , using a different technique to measure muscle capillary basement membrane width, was unable to duplicate these observations. However, Camerini-Davalos et al. (10) quantitated muscle capillary basement membrane width in the offspring of two diabetic parents using methods similar to those of Siperstein et al. (1) , and also found "that in certain subjects highly predisposed to diabetes on a genetic basis, changes may occur in the microvessels before detectable hyperglycemia" (10 (13) . Interestingly, these investigators did observe an increase in glomerular basement membrane width, tubular basement membrane width, and mesangial volume in the diabetic twins as compared with their nondiabetic identical siblings (13) .
Approaching this issue in a different way, Marks et al. measured the mean capillary basement membrane width in first degree relatives of children with insulin-dependent diabetes (14) . They found that muscle capillary membrane width was increased in the nondiabetic parents ofdiabetic children as compared with controls ( 14) . Moreover, the width of the muscle capillary basement membrane in the parents of diabetic children was related to HLA phenotype, with parents with HLA DR-4 having a muscle capillary basement membrane width greater than either the controls or parents without the DR-4 gene (14) . Taken together, these studies suggest that in addition to abnormalities in metabolic status, genetic factors also play a role in the development of diabetic microvascular disease.
To define better the relationship of genetic and environmental factors in diabetic microvascular disease one could determine the effect of secondary hyperglycemia on microangiopathy. Studies of the influence of conditions such as pancreatic disorders on microangiopathy and muscle capillary basement width have given contradictory results perhaps because a genetic predisposition to hyperglycemia in these conditions may contribute to the vascular lesions (1, (15) (16) (17) (18) (19) (20) . For this reason we have carried out a study of muscle capillary basement membrane width in subjects who developed hyperglycemia secondary to the ingestion of Vacor. Vacor is a rat poison which, when ingested, results in the destruction of the beta cells in the pancreas, in a fashion analogous to that of streptozotocin, and thereby induces diabetes (21) (22) (23) (24) (25) . In addition, Vacor also has extra pancreatic effects that contribute to the hyperglycemia (26) . Studies of muscle capillary basement membrane width in Vacor-induced hyperglycemia should therefore indicate whether hyperglycemia per se causes microangiopathy.
Methods
Controls, IDD, and Vacor-induced diabetics were recruited from the Endocrine-Metabolism Clinic of the Chonnam University Medical School. The individuals in all three groups were questioned regarding the presence or absence of any family members or relatives with diabetes mellitus and were excluded from the study if there was any history of diabetes mellitus in the family. In all cases, Vacor ingestion occurred during an unsuccessful suicide attempt. The procedure of Siperstein et al. was used to quantitate capillary basement membrane width (1) . In brief, a 10-20-mg biopsy of muscle was obtained from the lateral aspect of the quadriceps muscle at the point midway between the knee and the hip of each subject with a modified Franklin-Silverman needle. The biopsies were immediately fixed in Palade's buffered osmium tetroxide fixative. After 60 min of fixation the specimens were placed in 3.7% formaldehyde for 30 min and then dehydrated in ethanol. The samples were then coded and mailed to the Veterans Administration Medical Center for further analysis. The tissue was next embedded in Maraglas and ultra-thin sections were cut with a diamond knife. Electron micrographs were obtained with a Zeiss 1OA electron-microscope and in each individual the basement membrane thickness was measured as previously described. All measurements were made without knowledge ofthe group to which the patient belonged.
Serum creatinine levels were determined using reagents purchased from Gilford Diagnostics, Oberlin, OH, and glycosylated hemoglobin (HbA,) levels were determined using reagents provided by Sigma Chemical Co., St. Louis, MO. The presence of proteinuria was measured by routine urinalysis and the presence of retinopathy was determined by routine funduscopic examination.
The significance of difference between groups was assessed with a two-tailed t test and chi-square analysis.
Results
Tables I-IV present the clinical characteristics of the patients studied. The age and sex distribution is similar in the three groups. The duration of diabetes and serum creatinine levels in the insulin-dependent and Vacor-induced diabetic groups are also similar. As expected, the HbAI concentrations are increased in both diabetic groups in comparison to controls, but there are no differences between the IDD patients and the Vacor-induced diabetic patients. All the patients in the Vacor-induced diabetic group were receiving insulin therapy. In none ofthe three groups were there any individuals with a family history ofdiabetes mellitus. Note that despite the relatively short duration of diabetes, 44% of the Vacor-induced diabetic patients had evidence of retinopathy on routine funduscopic examination and 28% had proteinuria on routine urinalysis.
As shown in Tables I, II, III, These observations indicate that thickening of muscle capillary basement membrane occurs in Vacor-induced diabetes to a similar degree as observed in matched patients with insulin-dependent diabetes.
There is no correlation between muscle capillary basement membrane width and HbA, levels in either the IDD, the Vacorinduced diabetics, or both diabetic groups taken as a whole. In neither the insulin-dependent nor Vacor-induced diabetic is basement membrane width correlated with retinopathy or proteinuria, and an increase in muscle capillary basement membrane width in those patients with evidence ofclinical microangiopathy is not observed (IDD group: with microvascular disease (n = 5), 2,090+254 vs. without microvascular disease (n = 11), 2,376±176 NS; Vacor diabetic group: with microvascular disease (n = 10), 2,299±201 vs. without microvascular disease (n = 8), 2,346±236 NS).
Discussion
A number of different experiments in animals have suggested that the microvascular disease associated with diabetes is due to hyperglycemia or other factors associated with poor metabolic control. For example, experiments in rodents have shown that diabetes secondary to streptozotocin injection, alloxan administration, or pancreatectomy results in structural changes in the kidneys that are very similar but not identical to those observed prevents or retards the development of microvascular disease in humans with diabetic nephrectomy (27) . Moreover, the pre- (30) (31) (32) (33) (34) (35) (36) . vention of the hyperglycemia in the diabetic rodents by either Secondary diabetes has, in some reports but not all, been insulin administration or pancreatic transplantation prevented associated with increased thickening of the muscle capillary the development of these structural changes in the kidney (27) . basement membrane, diabetic retinopathy, or diabetic neSimilarly, in alloxan-induced diabetes in dogs, Engerman et al.
phropathy (1, (15) (16) (17) (18) (19) (20) . However, only a minority ofpatients with observed that the poorly controlled hyperglycemic animals had these conditions (chronic pancreatitis, hemochromatosis) dean increased number of retinal microaneurysms in comparison velop overt diabetes, which raises the possibility that those inwith animals whose diabetes was well controlled (28) . Additiondividuals who become hyperglycemic may have been selected ally, thickening ofthe glomerular capillary wall and the mesangial by a genetic predisposition to the development of diabetes. In region occurs more commonly and was more severe in the poorly the present study the potential confounding influence ofa genetic controlled diabetic dogs (28) . Streptozotocin-induced diabetes predisposition contributing to the microvascular disease has been in monkeys has also been shown to result in both increased avoided. In the extensive Korean experience with Vacor poimuscle and glomerular capillary basement membrane thickening soning, the ingestion ofthis agent has resulted in hyperglycemia (29) . These studies and others, therefore, support the hypothesis in a very large percentage ofindividuals (26) . As a result, Vacorthat an elevated blood glucose level or other abnormalities that induced diabetes is the first model in humans analogous to the occur in association with poorly controlled diabetes lead to the induced diabetic models in animals. This condition therefore microvascular changes that occur in patients with diabetes melpresents a unique opportunity in which to study the relationship litus. It should be recognized, though, that to date, studies in between hyperglycemia, independent of genetic diabetes, and humans have not demonstrated that tight metabolic control microangiopathy in humans. (23, 24) the muscle capillary basement membrane width was 1,612±87 A and 2,261±185 A, respectively. All three of these values are higher than those observed in concurrently measured nondiabetic individuals and are thus consistent with the observations of the present study. Lee et al. in a smaller group of Korean Vacor-induced diabetics has also observed a thickening of the muscle capillary basement membrane (37) .
In addition to the thickening ofthe muscle capillary basement membrane, it should also be noted that in our patients with Vacor-induced diabetes of relatively short duration (6.2±0.3 yr), 44% had evidence of retinopathy on routine funduscopic examination and 28% had proteinuria on routine urinalysis. These findings indicate that, as observed in animal experiments, the induction of diabetes by ingestion of a compound toxic to the beta cells of the pancreas not only results in hyperglycemia, but also leads to the microvascular changes associated with diabetes mellitus. Ofcourse it is possible that Vacor ingestion per se leads to the microvascular changes observed, but this seems an extremely remote possibility.
The results of this study-along with (a) the data presented in the Introduction section demonstrating that improved glycemic control results in a decrease in muscle capillary basement membrane width; (b) the studies demonstrating that kidneys from nondiabetics transplanted into diabetic patients develop morphological changes similar to those that occur in diabetic nephropathy and that these changes can be prevented by tight metabolic control (38, 39) ; and (c) the isolated case report demonstrating that the transplantation of diabetic kidneys into nondiabetic hosts results in the almost complete resolution of the diabetic lesion over a 7-mo period of observation (40) -all strongly support the hypothesis that the diabetic environment can be a primary cause and major aggravating factor in the microvascular changes of diabetics.
In summary, while data from this and other laboratories clearly demonstrate that genetic factors in the absence of hyperglycemia can cause thickening of muscle capillary basement width, the findings of the present study provide strong evidence that hyperglycemia, or some other abnormality that occurs in insulinopenic states, can itself cause the microvascular changes that occur in patients with diabetes mellitus.
